Literature DB >> 10523632

Targeted disruption of the murine fps/fes proto-oncogene reveals that Fps/Fes kinase activity is dispensable for hematopoiesis.

Y Senis1, R Zirngibl, J McVeigh, A Haman, T Hoang, P A Greer.   

Abstract

The fps/fes proto-oncogene encodes a cytoplasmic protein-tyrosine kinase that is functionally implicated in the survival and terminal differentiation of myeloid progenitors and in signaling from several members of the cytokine receptor superfamily. To gain further insight into the physiological function of fps/fes, we targeted the mouse locus with a kinase-inactivating missense mutation. Mutant Fps/Fes protein was expressed at normal levels in these mice, but it lacked detectable kinase activity. Homozygous mutant animals were viable and fertile, and they showed no obvious defects. Flow cytometry analysis of bone marrow showed no statistically significant differences in the levels of myeloid, erythroid, or B-cell precursors. Subtle abnormalities observed in mutant mice included slightly elevated total leukocyte counts and splenomegaly. In bone marrow hematopoietic progenitor cell colony-forming assays, mutant mice gave slightly elevated numbers and variable sizes of CFU-granulocyte macrophage in response to interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF). Tyrosine phosphorylation of Stat3 and Stat5A in bone marrow-derived macrophages was dramatically reduced in response to GM-CSF but not to IL-3 or IL-6. This suggests a distinct nonredundant role for Fps/Fes in signaling from the GM-CSF receptor that does not extend to the closely related IL-3 receptor. Lipopolysaccharide-induced Erk1/2 activation was also reduced in mutant macrophages. These subtle molecular phenotypes suggest a possible nonredundant role for Fps/Fes in myelopoiesis and immune responses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523632      PMCID: PMC84737          DOI: 10.1128/MCB.19.11.7436

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  66 in total

1.  The common src homology region 2 domain of cytoplasmic signaling proteins is a positive effector of v-fps tyrosine kinase function.

Authors:  C A Koch; M Moran; I Sadowski; T Pawson
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

2.  Lymphoid and mesenchymal tumors in transgenic mice expressing the v-fps protein-tyrosine kinase.

Authors:  S P Yee; D Mock; P Greer; V Maltby; J Rossant; A Bernstein; T Pawson
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

3.  Cardiac and neurological abnormalities in v-fps transgenic mice.

Authors:  S P Yee; D Mock; V Maltby; M Silver; J Rossant; A Bernstein; T Pawson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

4.  Isolation and sequence analysis of a novel human tyrosine kinase gene.

Authors:  Q L Hao; N Heisterkamp; J Groffen
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

5.  Circadian variations in mouse bone marrow.

Authors:  N P Aardal; O D Laerum
Journal:  Exp Hematol       Date:  1983-10       Impact factor: 3.084

6.  Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy.

Authors:  R J Tushinski; I T Oliver; L J Guilbert; P W Tynan; J R Warner; E R Stanley
Journal:  Cell       Date:  1982-01       Impact factor: 41.582

7.  Phosphatidylinositol kinase activity associates with viral p60src protein.

Authors:  Y Fukui; H Hanafusa
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

8.  A murine fer testis-specific transcript (ferT) encodes a truncated Fer protein.

Authors:  K Fischman; J C Edman; G M Shackleford; J A Turner; W J Rutter; U Nir
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

9.  src- and fps-containing avian sarcoma viruses transform chicken erythroid cells.

Authors:  P Kahn; B Adkins; H Beug; T Graf
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

10.  K562 leukemia cells transfected with the human c-fes gene acquire the ability to undergo myeloid differentiation.

Authors:  G Yu; T E Smithgall; R I Glazer
Journal:  J Biol Chem       Date:  1989-06-15       Impact factor: 5.157

View more
  10 in total

1.  Activated Fes protein tyrosine kinase induces terminal macrophage differentiation of myeloid progenitors (U937 cells) and activation of the transcription factor PU.1.

Authors:  Jynho Kim; Ricardo A Feldman
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

2.  The KRAB-associated co-repressor KAP-1 is a coiled-coil binding partner, substrate and activator of the c-Fes protein tyrosine kinase.

Authors:  Frank J Delfino; Jonathan M Shaffer; Thomas E Smithgall
Journal:  Biochem J       Date:  2006-10-01       Impact factor: 3.857

3.  Enhanced endotoxin sensitivity in fps/fes-null mice with minimal defects in hematopoietic homeostasis.

Authors:  Ralph A Zirngibl; Yotis Senis; Peter A Greer
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

4.  Mice devoid of fer protein-tyrosine kinase activity are viable and fertile but display reduced cortactin phosphorylation.

Authors:  A W Craig; R Zirngibl; K Williams; L A Cole; P A Greer
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

5.  A point mutation in the N-terminal coiled-coil domain releases c-Fes tyrosine kinase activity and survival signaling in myeloid leukemia cells.

Authors:  H Y Cheng; A P Schiavone; T E Smithgall
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

6.  Fes tyrosine kinase expression in the tumor niche correlates with enhanced tumor growth, angiogenesis, circulating tumor cells, metastasis, and infiltrating macrophages.

Authors:  Shengnan Zhang; Violeta Chitu; E Richard Stanley; Bruce E Elliott; Peter A Greer
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

7.  Fer kinase is required for sustained p38 kinase activation and maximal chemotaxis of activated mast cells.

Authors:  Andrew W B Craig; Peter A Greer
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

8.  FES-Cre targets phosphatidylinositol glycan class A (PIGA) inactivation to hematopoietic stem cells in the bone marrow.

Authors:  P Keller; J L Payne; G Tremml; P A Greer; M Gaboli; P P Pandolfi; M Bessler
Journal:  J Exp Med       Date:  2001-09-03       Impact factor: 14.307

9.  Chemical genetics strategy to profile kinase target engagement reveals role of FES in neutrophil phagocytosis.

Authors:  Tom van der Wel; Riet Hilhorst; Hans den Dulk; Tim van den Hooven; Nienke M Prins; Joost A P M Wijnakker; Bogdan I Florea; Eelke B Lenselink; Gerard J P van Westen; Rob Ruijtenbeek; Herman S Overkleeft; Allard Kaptein; Tjeerd Barf; Mario van der Stelt
Journal:  Nat Commun       Date:  2020-06-25       Impact factor: 14.919

10.  The Fer tyrosine kinase regulates an axon retraction response to Semaphorin 3A in dorsal root ganglion neurons.

Authors:  Zoya Shapovalova; Kyrylo Tabunshchyk; Peter A Greer
Journal:  BMC Dev Biol       Date:  2007-11-30       Impact factor: 1.978

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.